Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapy. [PDF]
Salvati L +10 more
europepmc +1 more source
A Pediatric Case of Reversible Eosinophilic Duodenitis Associated With Sublingual Immunotherapy. [PDF]
Yabe K +5 more
europepmc +1 more source
Three-year sublingual immunotherapy for HDM-induced allergic rhinoconjunctivitis: sustained ocular symptom improvement. [PDF]
Liu C, Jiang H, Long Y, Jiang F, Chen L.
europepmc +1 more source
Methodological concerns regarding the meta-analysis of 300 IR 5-grass pollen sublingual immunotherapy tablets. [PDF]
Di Lorenzo G, Melluso M.
europepmc +1 more source
Immunological effects of subcutaneous and sublingual immunotherapy in house dust mite-allergic adults: a nine-month prospective pilot study. [PDF]
Taha SI +4 more
europepmc +1 more source
Real-Life Safety of Japanese Cedar Pollen Sublingual Immunotherapy Tablets: A Post-Marketing Survey. [PDF]
Gotoh M +5 more
europepmc +1 more source
Effect of initiation treatment timing on efficacy of <i>Artemisia Annua</i> sublingual immunotherapy in patients with allergic rhinitis. [PDF]
Li J +8 more
europepmc +1 more source
ORALAIR: A novel sublingual immunotherapy
Arpita Singh +6 more
doaj +1 more source
Effects of sublingual immunotherapy for dust mite on Th 17 / Treg cells in children with asthma. [PDF]
Li F +5 more
europepmc +1 more source
Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatrics. [PDF]
Devillier P +11 more
europepmc +1 more source

